MentalHealthDaily

Accelerated TMS for Depression: Is aTMS More Effective than Standard TMS? (2024 Review)

by GLOOM

Depression, a common yet severe mood disorder, affects millions worldwide, posing significant challenges in both diagnosis and treatment. Recent advancements have led to the development of accelerated transcranial magnetic stimulation (aTMS), a novel approach aiming to offer rapid relief for individuals suffering from major depressive disorder (MDD). This revolutionary technique has shown promising results, potentially …

Dietary Sugar Intake & Depression: 100g/day Increase Equals 28% Higher Risk (NHANES Data: 2011-2018)

by GLOOM

In recent years, the intricate relationship between dietary habits and mental health has come under scientific scrutiny, revealing insights that challenge our daily consumption choices. Specifically, the consumption of dietary sugar has been identified as a potential factor influencing the prevalence of depression among adults in the United States. A study utilizing data from the …

Abnormal EEG Microstates Linked to Major Depression & Related Cognitive Impairment (2024 Study)

by GLOOM

In the quest to understand the enigmatic nature of depression, scientists are turning to the intricate patterns of brain activity, seeking clues hidden within the electrical storm of thoughts and emotions. By examining electroencephalography (EEG) microstates—brief, recurring patterns of brain activity—researchers have begun to piece together how depression alters the fundamental dynamics of the brain. …

Gut Bacteria Composition in Major Depression vs. Healthy Controls & Antidepressant Treatment (2024 Study)

by GLOOM

Depression, a multifaceted disorder characterized by pervasive sadness and lack of interest, extends beyond the brain to implicate the entire body, including the gut. Recent research has illuminated the significant role that gut microbiota plays in Major Depressive Disorder (MDD), suggesting a complex interplay between our microbial inhabitants and mental health. Highlights: Gut Microbiota & …

Cytokine Profiles in Major Depression (Low IL-17C) & Comorbid Anxiety (2024 Study)

by GLOOM

Recent studies have shed light on the intricate relationship between cytokines—proteins crucial for cell signaling in the immune system—depression, and anxiety. This exploration is pivotal in unveiling the potential biomarkers and therapeutic targets for major depressive disorder (MDD), particularly in patients experiencing their first episode and those untreated with drugs, with or without comorbid anxiety. …

Escitalopram (Lexapro) Normalizes Brain Connectivity in Major Depression (2024 Study)

by GLOOM

Major Depressive Disorder (MDD) significantly alters the brain’s network connectivity, with disturbances in the default mode network (DMN), salience network (SN), and dorsal attention network (DAN). A new study reveals how escitalopram, a common antidepressant, can partially reverse these abnormalities, offering insights into the biological underpinnings of its therapeutic effects. This research deepens our understanding …

Zuranolone for Depression: Rapid Efficacy & Safety in Clinical Trials (2023 Review)

by GLOOM

Zuranolone, a novel antidepressant, shows promise in treating depression, as evidenced by a recent meta-analysis. A new study investigated zuranolone’s efficacy and safety, focusing on short-term rapid antidepressant effects. Highlights: Zuranolone Effectiveness: Demonstrated significant improvement in depression severity scores compared to placebo, with notable effects by day 15. Treatment-Emergent Adverse Events (TEAEs): Increased incidence in …